KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Colgate Palmolive (CL) Shares Outstanding (Weighted Average) (2016 - 2026)

Colgate Palmolive has reported Shares Outstanding (Weighted Average) over the past 18 years, most recently at $802.3 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 1.19% year-over-year to $802.3 million; the TTM value through Mar 2026 reached $802.3 million, down 1.19%, while the annual FY2025 figure was $808.7 million, 1.27% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 was $802.3 million at Colgate Palmolive, down from $808.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $840.6 million in Q1 2022 and troughed at $802.3 million in Q1 2026.
  • A 5-year average of $823.1 million and a median of $822.8 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 0.82% in 2022 and later fell 1.34% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $836.4 million in 2022, then fell by 1.08% to $827.4 million in 2023, then decreased by 1.0% to $819.1 million in 2024, then dropped by 1.27% to $808.7 million in 2025, then fell by 0.79% to $802.3 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CL at $802.3 million in Q1 2026, $808.7 million in Q4 2025, and $810.0 million in Q3 2025.